Human Immunodeficiency Virus and Genital Herpes -
56,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
28 °P sammeln
  • Broschiertes Buch

Herpes simplex virus (HSV) infection the causative agent for genital herpes is an important cofactor in HIV transmission. Published evidence indicates that continued transmission is facilitated by the large number of undiagnosed cases, the frequency of atypical or pauci-symptomatic disease and the occurrence of asymptomatic shedding. This book describes: i) the diagnostic advantages of PCR as a gold standard test for screening high-prevalence populations; ii) the risk factors associated with genital HSV type-1 and type-2 infections and its influence on the acquisition of genital herpes in HIV…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Herpes simplex virus (HSV) infection the causative agent for genital herpes is an important cofactor in HIV transmission. Published evidence indicates that continued transmission is facilitated by the large number of undiagnosed cases, the frequency of atypical or pauci-symptomatic disease and the occurrence of asymptomatic shedding. This book describes: i) the diagnostic advantages of PCR as a gold standard test for screening high-prevalence populations; ii) the risk factors associated with genital HSV type-1 and type-2 infections and its influence on the acquisition of genital herpes in HIV positive individuals and iii) the reconstitution of HSV-specific T-cell responses in HIV infected patients and healthy controls. Although strategies to limit the spread of HSV genital infection in HIV infected patients remain challenging, clearly an effective HSV vaccine is urgently required to lower transmission rates. The book provides new insights into the management and diagnostic issuessurrounding genital herpes in HIV infected patients and serves to be a comprehensive resource for clients in medicine, pharmaceutical and health sectors.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr Meghna Ramaswamy is the Project Leader for the Centre for AIDS Reagents, UK. She concluded her PhD studies in 2005. Her research interests focus on the development of HIV/AIDS preventative strategies. She is a Scientific Advisor for the World Health Organisation and a Steering Committee Member for five international AIDS initiatives.